Qi Jiang

Author PubWeight™ 82.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 2011 11.28
2 Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 2010 9.29
3 Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 2011 6.16
4 hDOT1L links histone methylation to leukemogenesis. Cell 2005 5.83
5 Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L. Nat Cell Biol 2006 1.97
6 Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 2005 1.89
7 1.3-μm InAs/GaAs quantum-dot lasers monolithically grown on Si substrates using InAlAs/GaAs dislocation filter layers. Opt Express 2014 1.82
8 Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. J Clin Invest 2010 1.74
9 The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med 2005 1.70
10 Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid. Clin Cancer Res 2012 1.26
11 Preservation of effect and the regulatory approval of new treatments on the basis of non-inferiority trials. Stat Med 2008 1.18
12 Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis. Immunol Res 2008 1.11
13 Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals. Mol Cancer Ther 2013 1.10
14 Elevated serum polybrominated diphenyl ethers and thyroid-stimulating hormone associated with lymphocytic micronuclei in Chinese workers from an E-waste dismantling site. Environ Sci Technol 2008 1.08
15 A genetic approach to inactivating chemokine receptors using a modified viral protein. Nat Biotechnol 2003 1.07
16 On the clinical meaningfulness of a treatment's effect on a time-to-event variable. Stat Med 2011 1.07
17 New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells. J Mol Cell Biol 2012 1.07
18 Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model. J Virol 2009 1.05
19 Responder analyses and the assessment of a clinically relevant treatment effect. Trials 2007 0.99
20 Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation. J Biol Chem 2012 0.99
21 Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer 2012 0.99
22 Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study. Antimicrob Agents Chemother 2002 0.96
23 Relevance of serum estradiol and estrogen receptor beta expression from a high-incidence area for esophageal squamous cell carcinoma in China. Med Oncol 2010 0.96
24 Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2⁻/⁻γ C⁻/⁻ mice in vivo. Blood 2011 0.96
25 An overview of prostate diseases and their characteristics specific to Asian men. Asian J Androl 2012 0.96
26 Unique sodium phosphosilicate glasses designed through extended topological constraint theory. J Phys Chem B 2014 0.95
27 Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development. Mol Endocrinol 2012 0.94
28 Assessment of futility in clinical trials. Pharm Stat 2007 0.94
29 Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program. Chin Med J (Engl) 2005 0.92
30 Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China. Helicobacter 2012 0.92
31 Informative noncompliance in endpoint trials. Curr Control Trials Cardiovasc Med 2004 0.89
32 Galpha13 mediates a signal that is essential for proliferation and survival of thymocyte progenitors. J Exp Med 2004 0.88
33 A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults. Urology 2002 0.88
34 Controlling the type 1 error rate in non-inferiority trials. Stat Med 2008 0.87
35 Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. J Antimicrob Chemother 2004 0.86
36 Estimating minimally important differences for the worst pain rating of the Brief Pain Inventory-Short Form. J Support Oncol 2011 0.85
37 Anti-depressant effects of aqueous extract from Acanthopanax senticosus in mice. Phytother Res 2013 0.85
38 Fiber optic pressure sensing with conforming elastomers. Appl Opt 2010 0.84
39 [Long-term immunogenicity and effectiveness of live attenuated hepatitis A vaccine (H2-strain)-a study on the result of 15 years' follow up]. Zhonghua Liu Xing Bing Xue Za Zhi 2010 0.84
40 Identifying early urinary metabolic changes with long-term environmental exposure to cadmium by mass-spectrometry-based metabolomics. Environ Sci Technol 2014 0.84
41 In vitro protective effects of pyrroloquinoline quinone on methylmercury-induced neurotoxicity. Environ Toxicol Pharmacol 2008 0.82
42 Primary stromal cells isolated from human various histological/pathological prostate have different phenotypes and tumor promotion role. Chin Med J (Engl) 2011 0.82
43 Safety monitoring in clinical trials. Pharmaceutics 2013 0.82
44 Zonal differences in prostate diseases. Chin Med J (Engl) 2012 0.80
45 InAs/GaAsSb quantum dot solar cells. Opt Express 2014 0.80
46 Protective effects of aqueous extract from Acanthopanax senticosus against corticosterone-induced neurotoxicity in PC12 cells. J Ethnopharmacol 2013 0.79
47 A CAPE analogue as novel antiplatelet agent efficiently inhibits collagen-induced platelet aggregation. Pharmazie 2014 0.79
48 Biomimetic peptoid oligomers as dual-action antifreeze agents. Proc Natl Acad Sci U S A 2012 0.79
49 Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer. Urology 2012 0.78
50 Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants. Med Oncol 2014 0.78
51 Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone. Clin Ther 2002 0.78
52 Caspase-dependent molecular mechanisms of anti-human DR5 monoclonal antibody mDRA-6 inducing apoptosis of human leukemia Jurkat cells. Ai Zheng 2009 0.77
53 A novel agonistic anti-human death receptor 5 monoclonal antibody with tumoricidal activity induces caspase- and mitochondrial-dependent apoptosis in human leukemia Jurkat cells. Cancer Biother Radiopharm 2011 0.77
54 Indirect comparisons in the comparative efficacy and non-inferiority settings. Pharm Stat 2011 0.77
55 Predicting analysis time in event-driven clinical trials with event-reporting lag. Stat Med 2012 0.76
56 A counterfactual p-value approach for benefit-risk assessment in clinical trials. J Biopharm Stat 2015 0.75
57 Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression. Asian J Androl 2013 0.75
58 The role of urethral pressure profile on treating premature ejaculation by tamsulosin. Asian J Androl 2014 0.75
59 InAs/GaAs quantum-dot superluminescent diodes monolithically grown on a Ge substrate. Opt Express 2014 0.75
60 Effects of extracellular environment factors on the motility in Japanese eel spermatozoa. Cell Biol Int 2011 0.75
61 [Analysis of the impact of two typical air pollution events on the air quality of Nanjing]. Huan Jing Ke Xue 2012 0.75
62 In situ annealing enhancement of the optical properties and laser device performance of InAs quantum dots grown on Si substrates. Opt Express 2016 0.75
63 [Clinical observational study of anemia in mechanically ventilated patients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2012 0.75
64 [Characterization of stromal cell cultures from the prostatic peripheral zone of men at different ages]. Zhonghua Nan Ke Xue 2011 0.75
65 [Impacts of ultraviolet irradiation on the sperm motility and longevity of Acipenser baerii]. Ying Yong Sheng Tai Xue Bao 2011 0.75
66 Continuous-wave InAs/GaAs quantum-dot laser diodes monolithically grown on Si substrate with low threshold current densities. Opt Express 2012 0.75
67 Evaluation of statistical methods for safety signal detection: a simulation study. Pharm Stat 2014 0.75
68 Analysis of multiple endpoints in clinical trials: it's time for the designations of primary, secondary and tertiary to go. Pharm Stat 2011 0.75
69 [Polymorphisms of hsp 60 gene in Chinese Han people]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2006 0.75
70 The issue of multiplicity in noninferiority studies. Clin Trials 2012 0.75
71 A Contemporary Assessment of Acute Mechanical Ventilation in Beijing: Description, Costs, and Outcomes. Crit Care Med 2017 0.75
72 [Spatial distribution of three endocrine disrupting chemicals in sediments of the Suzhou Creek and their environmental risks]. Huan Jing Ke Xue 2012 0.75
73 [Research on cytokines gene express of rats alcoholic liver disease affected by tea polyphenol]. Zhongguo Zhong Yao Za Zhi 2005 0.75